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Chapter 1- Introduction

This thesis focuses on the analysis of factors that influence medication adherence

in HIV infected adolescents treated at the University of Connecticut Health Center and

the Connecticut Children’s Medical Center (UCHC/CCMC) HIV Pediatric and Youth

Program.

The effects of HIV/AIDS on adolescents and young adults are a major concem in
the United States. Increasing numbers of young people are becoming infected as sexual
behavior and drug use is initiated earlier in adolescent development. In addition to those

adolescents who contract HIV/AIDS during their adolescence, there is another group of
adolescents who have been seropositive all their lives through mother to child
transmission and, as a result of more efficacious treatments, are now reaching the age of

puberty. As a result, there is an urgent need for the health care providers to have the
social, clinical and psychological skills to assist young people to adhere to complex

therapeutic regimes and adopt a healthy lifestyle.

According to the Center for Diseases Control (CDC 2003) the number of AIDS
cases for children under 13 years old is estimated to be 9,419 cases nationwide.

Prevalence of HIV infected adolescents has been difficult to obtain because reporting of

HIV with confidential name or code has only been initiated in recent years in Connecticut
in 2002 (Conn. Epidemiologist 2001).

The CDC reported 38,490 cumulative cases of AIDS among people 13 to 24 years
old through 2003. It is estimated that 10,041 adolescents and young adults with AIDS

have died since the epidemic began and the proportion of adolescents diagnosed with

AIDS has increased from 3.9 percent in 1999 to 4.7 percent in 2003. Because the average
time it takes for the HIV infection to develop into AIDS is 10 years, most adults

diagnosed with AIDS in their twenties were likely infected as adolescents or young
adults. In 2003, an estimated 3,897 adolescents and young adults were newly diagnosed
with HIV/AIDS nationwide, while an estimated 13,752 were living with HIV/AIDS.

Experts in the health field estimate the number of adolescents and young adults to be
much higher (Department of Health And Human Services 2003).

Large epidemiological surveys (applicants to job corps, military services and
voluntary counseling and testing) indicate that seroprevalence of HIV is higher in certain
populations of youth in comparison with the general population.

Specifically,

seroprevalence of HIV is greater among disadvantaged (African American and Latino)
out-of-school youth, teens in the rural south and urban areas in the northeast, homeless
and runaway adolescents and young men who are gay or bisexual (Conway et al. 1998).
African American and Hispanic adolescents have been disproportionately affected by
HIV/AIDS. African Americans and Hispanics from 13-19 years of age accounted for 66

percent and 21 percent, respectively, of the reported AIDS cases in 2003

Department of Health and Human Services 2005).

(U.S.

Since the first treatment of HIV infected children with Zidouvine monothererapy

in 1993, dramatic advances in laboratory and clinical research have been made. New
tests that quantify plasma HIV RNA copy numbers have become available and permit a

sensitive assessment of the disease progression and the adequacy of antiretroviral

therapy. New medications that reduce the HIV viral load to levels that are undetectable
have become available and have decreased the progression of the disease. Therefore,
treatments now focus on the use of combination therapies that maximize the reduction of

the virus.

The recommended guidelines for treating children and adolescents infected with

HIV are a combination of antiretroviral therapies termed Highly Active Antiretroviral
Therapy (HAART). Children and youth who receive such therapy have derived clinical
and immunologically benefit and are living longer lives.

However, the long-term

effectiveness of antiretroviral medications is dependent upon the appropriateness of the

chosen regimen, adequate dosing, strict follow-up of virologic response and strict
adherence to the prescribed regimen.

Sub-therapeutic doses of these medications will

result in mutant viruses that are generally drug resistance.

Resistance facilitates

progression of the HIV infection, related complications and ultimately death. In addition,
drug-resistant strains of HIV are a public health issue (Martinez et al. 2000). As HIV
infected individuals engage in risk behaviors, transmission of such strains are potentially

introduced into the community, making treatment more difficult.

Today’s health service providers are facing issues of HIV infection from a chronic
care perspective. Literature describing the generic approach to chronic disease (Stein et

al. 1993) defines the following characteristics" the need for ongoing specialist medical

care, slow degeneration of health, pain and discomfort, psychological and emotional
impact, impairment to engage in usual expected activities and premature death. These
characteristics are now shared by those with HIV, yet this disease has other unique

aspects such as: stigma, secrecy, social isolation, interaction with family problems, such
as drug addiction, multigenerational impact and multiple losses in the family (Lewis et al.

1994).

Adolescents with HIV face barriers to medication adherence due to the

complexity of the medical regimen, adverse side effects, the developmental tasks of their
age, lack of social support, double and sometimes triple diagnoses such as drug abuse,

STDs, arrested development, mental diagnoses such as bipolar, depression, ADHD, not to
mention the difficulty they have in accepting both the chronic and life-threatening nature

of their illness. HAART is difficult to manage in terms of scheduling, appropriate doses,

drug interaction and toxicities. Physiological changes in early adolescence affect the
metabolism of certain medications. A better understanding is needed of the interrelations

between developmental age and appropriate drug dosages. Despite the efforts of the

pharmaceutical industry to minimize the amount of pills by combining two or three
medications into one pill, the need remains for adolescents to take medications two or

three times a day and to take medication under particular conditions (some on an empty

stomach while others with food). The side effects of some medications inhibit the

antiretroviral activity of other drugs and the drugs can potentially cause birth defects in

young pregnant women while others cause diarrhea, nausea, headache and body
deformation (lipodistrophy). Some pills are big and difficult to swallow. Adolescents

frequently have difficulty grasping the relationship between adherence to medication and
prevention of disease progression. Asymptomatic adolescents have difficulty accepting
the implications of a serious illness when they still feel well (example of concrete

thinking). Others prefer the use of marihuana to the medication because according to
them it made them feel better than the medications. A better understanding is needed of
the interrelations between developmental age and appropriate drug dosages.

The challenges associated with adolescent developmental stages bring another set
of issues that make the adherence to medications difficult. In early adolescence, concrete

thinking makes it difficult for young adolescents to grasp the notion that medication
adherence is needed in order to keep themselves healthy. They are more concerned with
the pubertal changes such as physical appearance and growing sexual awareness. In the
middle adolescent stage, the need for acceptance from peers plays an enormous role in
their lives. They have the urgency to feel normal and to behave in a manner that is
consistent with their peers. Their orientation to the present decreases their ability to plan

for the furore and reduces the priority of taking medications.

Also, many adolescents

have busy, unstructured lives that do not facilitate the necessary planning for

appointments and medication compliance. Many high school students that begin their
school day at seven in the morning do not have time to have breakfast or take their
medications. The single parent household may be overwhelmed and cannot offer the

encouragement teenagers need to keep up with their medications. Many times the
economic stresses of the household require that the adult is gone from the home holding
two jobs or in some circumstances is involved with illegal drugs, which brings a whole

set of other dynamics into the teenager’s life.

The last stage of adolescent life is

characterized by the establishment of independence and feelings of immortality. It is a

very stressful time for some of them. Some adolescents look for independence by finding

partners and living with them while others just rebel against their parents or caregivers
and end up homeless or in detention centers.

The psychological effects of HIV infection on children and adolescents range
from mild to devastating. Factors such as cognitive deficiencies, emotional, mental

impairments and behavioral problems affect the way adolescents adhere to medication.
Cognitive factors are even more important for adolescents with HIV who can have

problems with language, memory, attention, as well as intellectual deficits (Wolters et al.

1995). Failure to recognize specific cognitive problems in adolescents who are or appear
to be functioning at age level may cause caregivers or clinicians to place an inappropriate

degree of responsibility on them.

There are clinical reports that suggest that HIV infected children and adolescents
are at risk for anxiety, depression and behavioral problems. A study of antiretroviral

adherence among HIV infected adolescents (Murphy et al. 2005) found that the strongest

and most consistent finding was the relationship between depression and adherence. A

survey of personnel participating in a multi-center Pediatric AIDS Clinical Trials

(PACTG) in 2001 revealed that learning, behavioral, and emotional problems are as
frequent as 70-95% of children and adolescents with HIV at the PACTG sites (Siros

2201). Also, there is research to suggest that psychological problems in HIV children
and adolescents are more related to environmental and demographic factors than the HIV
infection (Mellins et al. 2003). Many HIV positive youth have lived difficult childhoods

witnessing poverty, violence, substance abuse and sometimes they have been victims of

physical, emotional and sexual abuse. Therefore, psychiatric and emotional diagnoses
like depression, post-traumatic stress, and bipolar are frequent.

Understanding the

behavioral and psychological problems in HIV infected youth is critical to improving
their mental health, which has been associated with poor adherence. It is vital that mental

health needs be addressed, but to date, resources for mental health for HIV infected youth
have been very limited thanks to continued cuts in funding.

Sexuality is a major issue among HIV positive adolescents.

During no other

developmental time does the human body undergo so many changes as in the adolescence
stage. Sex hormones initiate the process of growth and sexual maturity. Adolescents

struggling to find their sexual identity are experimenting sexually, thereby putting their
health and their partner’s health at risk. Twenty-five percent of STDs reported in the

U.S. each year are among teenagers (U.S. Department of Health and Human Services)
and for young women there is the added risk of pregnancy. There is concern that HIV

positive young people are engaging in even riskier behavior than their HIV negative
counterparts. Hein and colleagues (1995) found that adolescents who are seropositive
had higher STD rates as a result of less condom use and engaged in substantially more

unprotected sex acts. As a result, they had almost double the number of sexually
transmitted diseases and were significantly more likely to engage in survival sex, sex
with casual partners, and to use condoms less often. Additionally, HIV positive male

adolescents were more likely to be sexually abused than their HIV negative counterparts.

Establishing relationships that for other teens are normal is emotionally charged
for HIV positive youth. They have the constant added burden of every time they meet
someone new deciding whether or not to disclose their HIV status to friends and romantic

partners. This can be a very painful process for teenagers who by their very nature fear
rejection and isolation. They are too young to stand up to violence that could be directed
at them. Keeping their HIV status secret is a reason for them to drop out of school.

They may feel shame or guilt and have difficulty disclosing their condition to their peers
or teachers. The whole attempt to keep their HIV status secret is another reason for them

not to take their medication. If they are not taking medication, they do not have to

explain or make up a lie. Family dynamics and the support they provide are regarded as
crucial factors in the compliance of chronically ill adolescents. Noncompliance has been

related to family conflicts, behavioral problems, avoidance behavior and denial

(Degotarty et al. 1996). Many HIV infected children and adolescents live with parents
who also are struggling with the disease or combating addictions and poverty. Many

adolescents have lost their parents due to death or because the state has taken custody of
the adolescents. Some live with relatives or have been adopted, while others are in

juvenal-detention centers.

Although family support is very much encouraged,

adolescence and the transition into adulthood can be stressful for parents and caregivers.

The struggle of HIV positive adolescents to become independent is compounded by the

overwhelming issues related to their disease, leading some of them to become suicidal,

homeless, school dropouts or adjudicated youth.

HIV care providers are dealing not with an epidemic but a syndemic (Singer

2006) where a combination of HIV, STDs, mental health, substance use and poverty
syndromes needs to be addressed. The enormous number of issues that are involved
require that the helping system attend not only to the medical component but also to the
intertwined factors that are affecting HIV positive adolescents at this unique stage in their
lives.

Chapter 2" Background

Historical View of the AIDS Epidemic

On June 5, 2006, the U.S. passed its first quarter of a century of dealing with the

AIDS pandemic. On June 5, 1981 the Center for Disease Control (CDC) reported the first
five cases of pneumocystis carini pneumonia in five healthy young men in Los Angeles.

These cases were recognized later as the first reported cases of acquired

immunodeficiency syndrome (AIDS). Since that time the disease has claimed 22 million
lives worldwide, including more than 500,000 in the United States (MMWR 2006).

Although countless efforts have been made to prevent and treat HIV by persons
and organizations inside and outside the US government, an estimated 40,000 new

persons are diagnosed every year in the United States and in 2006 more than one million

people are living with HIV/AIDS in this country. HIV has disproportionately affected
racial and ethnic minorities. From 1981 to 1995, whites were the predominant group of

persons with AIDS (47%). However, over time the proportion has changed; from 2001 to
2004 non-Hispanic blacks accounted for 51% and Hispanics accounted for 29.5%

(MMWR 2006).

The proportion of people living with AIDS two years after an AIDS diagnosis
from 1981 to 1992 was 44%, for people diagnosed from 1993 to 1995 it was 64% and
from 1996 to 2000 it was 85%.

The latest increase was primarily due to the highly

active antiretroviral therapy (HAART), which became the standard of care in 1996. The
use of HAART has slowed the disease progression, reducing the number of HIV positive

people who develop AIDS. Thanks to the use of these potent drugs many of the perinatal
infected children are today adolescents living with HIV.

Pediatric AIDS cases were reported as early as 1982 (MMWR 2006) and were
attributed to mother to child transmission. The estimated number of perinatally acquired

AIDS cases peaked in 1991 at 1,650 cases (Linder et al. 1999). After 1999 HIV
diagnoses declined to an estimated 144 to 236 cases in 2002 and 48 cases in 2004,

thereby achieving a 59% decrease since 1992 (MMWR 2006). The reduction of
perinatal infection is due to: 1) Routine HIV screening of pregnant women. 2) Some
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states like Connecticut reinforced this policy by passing laws to test newborn babies if the

mother had refused to be tested during pregnancy.

3) The use of antiretroviral

medications for treatment and prophylaxis during pregnancy for infected mothers. 4)
Avoidance of breastfeeding and the use of elective cesarean delivery when appropriate.

The use of these interventions during pregnancy for infected mothers and in labor or

delivery for women with undocumented HIV status has cut the rate of transmission to
less than 2% compared with transmission rates of 25% to 30% without intervention. In
the U. S., in spite of the effort to cut the transmission rates, there is still 7% of HIV
infected pregnant women that remain undiagnosed at the time of delivery. Issues of

mental health, substance use, and stigma are barriers for some women to get prenatal care

(MMWR 2006). Nonetheless, there is a cohort of perinatally HIV infected children and
youth that due to HAART are living longer. Despite their illness many of the infected
adolescents behave like their healthier counterparts in the general population. They use

drugs, have consensual sex and do not always use condoms, making them a potential
source of HIV transmission.

In addition, there are those adolescents who have become

infected with HIV through both sexual activity and injection drug use, but primarily from

sexual activity. However, drug use is an important factor even in sexually transmitted

HIV in adolescents since they may engage in high-risk sex after using drugs or in
exchange for drugs or money (Futterman et al. 1999). It is estimated that 40,000 people
are diagnosed with HIV every year in the U.S. and the trend continues to be that almost

half of them are under 25 years of age (NIAID HIV AIDS 2004).

11

Development of Medication Regimes

The replication of the HIV vires results in immune system damage and

progression to AIDS. Periodic measurement of HIV RNA (viral load) levels helps to
determine the risk of HIV disease progression and guides the clinicians as to when to
start or change HAART medications.

CD4 or T cell measurement monitors the

dysfunction of the immune system. Most antiretroviral drugs are approved for pediatric
use based on the efficacy data obtained in clinical trials for adults, with supporting data

for pharmacokinetic and safety from additional trials in children (Mofeson et al. 2005).

Current guidelines for the initiation of antiretroviral therapy in adults are also relevant for
post pubertal adolescents. Clinicians need to pay attention to the physiological changes
of early and late adolescents because the metabolism of certain medications can vary

considerably between 13 year olds and 18 year olds. The benefit of starting HAART in

people with asymptomatic HIV disease and CD4 counts of more than 200 cells/mm3 is
unknown. However, the majority of clinicians would offer therapy at a CD4 T cell
threshold of <350/mm3. The Department of Human and Health Services (DHHS 1998)
defined the principles of medication therapy for HIV for adults in 1998 and

recommended them for post-pubertal adolescents with the unique considerations related
to their age.
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The following outline provides clinicians with a general guidance rather than rigid
recommendations (DHHS 2005).
Clinical category

AIDS defining
illness or severe

CD4 Cell Count

Any value

Plasma HIV RNA

Recommendations

Any value

Treat

Any value

Treat

Any value

Treatment should
be offered with full
discussion of pros

symptoms (A)

Asymptomatic (AI)

Asymptomatic (BII)

CD4 T cells
<200/mm3

CD4 T
cells>200/mm3 but

< 350/mm3
Asymptomatic (CII)

Asymptomatic (DII)

& cons

CD4 T

>_100,000

cells>350/mm3

Most clinicians
recommend
deferring treatment

CD4 T cells

<100,000

>350/mm3

Defer therapy

The Pediatric Clinical Trials Group (PCTG) has been for many years the leading

group to carry out medication, cognitive, behavior and psychosocial trials for pediatric
and adolescent HIV patients. This group is sponsored by the National Institute of Allergy
and Infectious Diseases and bases its research trials in several hospitals and health centers
all over the country. In one of the publications (Broggly et al. 2005) PCTG revised the
evolution of the HIV pediatric antiretroviral therapy. The study described the changes in
treatment regimes that the pediatric HIV treatment went through in the U.S. from 1987 to

2003. Single or dual nucleoside reverse transcriptase inhibitors (NRTI) were used most

frequently through 1997. In 1998, two years after protease inhibitors were approved for
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adults, regimes of HAART that included a protease inhibitor became more frequently
used for children. From 1998 to 2003, 22% of the children in the study initiated HAART
with a regimen that at the time had not been recommended by pediatric guidelines. The

study also demonstrated that there was a lag between the identification of HAART and its
adoption in the pediatric community.

Benefits of HAART

The benefits of HAART have been demonstrated in several studies done in
children as well as in adults. Murphy et al. (2001) in a research project named Reaching

for Excellence in Adolescent Care and Health (REACH) found a strong association

between medication adherence and reduced viral loads and also, that a CD4 level of more
than or equal to 500 cells/mm3 was associated with adherence.

Murphy’s group

investigated adherence to HAART among HIV infected adolescents recruited from 13 US
cities in the project. This was the first large-scale disease progression study of HIV-

positive adolescents infected through sexual behavior or injection drug use. Of 161

subjects: 7% could not correctly identify all their prescribed medications; 11% could
identify them but reported never taking at least one medication; the majority (83%)

reported taking all of their medications at least some of the time, but only 50% of these

subjects reported full adherence. Therefore, only 41% of the sample reported full
adherence. Higher levels of depression were significantly associated with decreased

adherence, and a trend was found for an association between the number of medications
prescribed and adherence. Researchers recommended strict adherence to HAART to
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sustain suppression of viral replication, and to allow the immune system to recuperate

and reduce the risk of medication resistance.

The benefits of HAART have also been demonstrated in children. Gibb et al.

(2003) at the Pediatric European Network for Treatment of AIDS (PENTA) showed that
taking prescribed medication was associated with a virologic response. More children

reporting full adherence achieved HIV RNA of more than 400 copies/ml at 48 weeks
79% vs. 50% reporting only some non-adherence. Comments on difficulties taking the
medication were related to disclosure of their HIV status and unpleasant characteristics

(flavor and pill size) of the medication. This study also acknowledged that factors
relating to the caregiver, the child and the medication are all considered to be important
for good adherence. Social factors such as family dynamics were important in explaining
non-adherence.

Associated Problems with Adherence

The HIV positive adolescents face many unique challenges over and above the
disease itself due to their developmental status, neuropsychological deficiencies, mental

health problems and family dynamics and environmental predicaments. All of the above
affect the way the adolescents adhere to their medications.

At The HIV Center for Clinical and Behavioral Studies, New York State
Psychiatric Institute, Mellins et al. (2004) examined child psychosocial and
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caregiver/family factors influencing adherence to HAART in perinatally human
immunodeficiency virus (HIV)-infected children.

Although this study was done in

children, many of the factors studied pertain to adolescents. Seventy-five children (ages
3-13 years) who were taking the prescribed HAART and their primary caregivers were
recruited from 2 urban pediatric HIV programs. A battery of psychological assessments

and self-report adherence data were collected from all caregivers and 48 children who
were 7 years old or older. Forty percent of the caregivers and 56% of the children

reported missed doses of medication in the past month. Families in which the caregiver
or child reported missed doses
no missed doses

(non-adherent) were compared with families who reported

(adherent). Non-adherence was significantly more associated with older

children, worse parent-child communication, higher caregiver stress, lower caregiver

quality of life and worse caregiver cognitive functioning.

There was borderline

significance when association with (1) increased child responsibility for medications, (2)

HIV disclosure to the child and (3) child stress. Controlling for age, caregiver/family
factors were the most strongly associated with non-adherence, including worse parentchild communication, higher caregiver stress, less disclosure to others and quality of life.

A number of studies have analyzed the impact of the HIV virus on the cognitive,
neurological and behavioral functioning of people with HIV. Shanbhag et al. (2005) in a
retrospective study analyzed the course of neurocognitive functioning in children before
and after HAART.

One hundred forty-six perinatally HIV-infected children born

between June 1990 and May 2003 with at least 1 neurocognitive evaluation were
evaluated for neurocognitive standard testing scores as well as diagnoses of progressive
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encephalopathy, probable progressive encephalopathy, or static encephalopathy. They
also assessed the impact of combination antiretroviral therapy on neurocognitive
outcomes in perinatally HIV-infected patients.

Researchers found that combination

antiretroviral therapy is associated with improved neurocognitive outcomes in children
with perinatally acquired HIV. Since 1996, fewer children have been diagnosed with

progressive encephalopathy, and neurocognitive functioning is preserved over time in
those deemed neurocognitive healthy.

Neurocognitive testing is considered critical in

detecting subtle cognitive deficits and monitoring the neurocognitive progress of HIV
infected children and youth. Researchers in this study concluded that viral load and CD4
counts are marginally predictive of future neurocognitive changes in HIV persons.

Sometimes young people with problems with adherence have shown symptoms in

cognitive and behavioral areas. Jeremy et al. (2005) at the Pediatric AIDS Clinical Trials

Group studied the neuropsychological functioning and its correlation with viral load for
previously treated HIV-infected children who underwent a change in treatment regimen.
Thirteen age-appropriate measures of cognitive, neurological, and behavioral functioning
were administered to 489 HIV-infected children who were aged 4 months to 17 years and

had been treated previously for at least 16 weeks with antiretroviral therapy. These

clinically and immunologically stable children were randomized into 1 of 7 drug
treatment combinations and evaluated prospectively for 48 weeks with respect to changes

in neuropsychological performance and viral load. Neuropsychological functioning was

significantly poorer at baseline for the HIV-infected children as compared with
established norms for their age.

After 48 weeks of treatment, cognitive short-term
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memory, vocabulary and fine-motor score means were still below the norm for children
their age. Children with higher viral load had poorer cognitive, both-hands fine-motor,

and neurological signs at baseline but single-hand fine-motor skills and behavioral

functioning was not correlated with viral load. Poor neuropsychological functioning was
seen for HIV-infected children and was worse for children with higher viral loads.

Descriptive studies and clinical reports have suggested that HIV-positive children
and youth are at risk for behavioral problems. Inadequate control groups and sample
sizes have limited the ability of investigators to consider multiple influences that place

HIV-positive children and youth at risk for poor behavioral outcomes. Mellins et al.

(2003) examined the unique and combined influences of HIV, prenatal drug exposure,
and environmental factors on behavior in children who were perinatally exposed to HIV.

Participants included 307 children who were born to HIV-positive mothers (96 HIV
infected and 211 seroreverters) and enrolled in a natural history, longitudinal study of
women to infant HIV transmission. Caregivers completed parent behavioral rating scales

beginning when the children were 3 years old. Data were also collected on prenatal drug
exposure, child age, gender, ethnicity and caregiver relationship to child and birth

complications.

Comparing the HIV-infected children with perinatally exposed but

uninfected children from similar backgrounds failed to find an association between either

HIV status or prenatal drug exposure and poor behavioral outcomes. The strongest
correlates of increased behavioral symptoms were demographic characteristics. This

study suggests that although a high prevalence of behavioral problems does exist among
HIV-infected children, neither HIV infection nor prenatal drug exposure is the underlying
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cause. Rather, other biological and environmental factors are likely contributors toward

poor behavioral outcomes. Often behavioral problems encountered in HIV children and

youth make adherence to medication more difficult to manage.

Clinically and immunologically stable HIV-infected children have more frequent
behavioral problems than children their age. Nozyce et al. (2006) researched the
behavioral and cognitive characteristics of clinically and immunologically stable

antiretroviral-experienced HIV-infected children. Two hundred seventy-four previously
treated HIV-infected children aged 2 to 17 years were assessed for behavioral,

developmental, and cognitive functioning. Correlations between neuropsychological
measures, age, and CD4 counts were investigated.

The most common behavioral

problems, as measured by the Conners’ Parent Rating Scale, were psychosomatic (28%),
learning (25%), hyperactivity (20%), impulsive-hyperactive (19%), conduct (16%), and
anxiety (8%) for HIV positive children than established population norms; the mean
verbal IQ was 85, the mean performance IQ was 90, and the mean full-scale score was
86. Hyperactivity was more frequent in children with a Wechsler Intelligence Scale for
Children-III performance IQ of <90. Anxiety problems were more likely in children 9

years of age or older. Children with CD4 counts of less than 660 cells per mm3 were
more likely to be identified as having a conduct disorder.

Clinical reports from the United States indicate substantive mental health

problems in perinatally HIV-infected youth that pose substantial barriers to adherence

and, therefore, to optimizing their health. The study conducted by Mellins et al. (2006)
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found that standardized assessments of mental health identified very high rates of

psychiatric disorders, primarily in the anxiety and behavioral domains in a sample of

youth with perinatal HIV infection.

This pilot study explored rates and types of

psychiatric and substance use disorders, as well as, emotional and behavioral functioning
in perinatally HIV-infected children and adolescents. Forty-seven perinatally-infected

youths (9-16 years of age) and their primary caregivers recruited from a pediatric HIV
clinic were interviewed using standardized assessments of youth psychiatric disorders

and emotional and behavioral functioning, as well as measures of health and caregiver’s
mental health. According to either the caregiver or child’s report, 55% of youths met
criteria for a psychiatric disorder. The most prevalent diagnoses were anxiety disorders

(40%), attention deficit hyperactivity disorders (21%), conduct disorders (13%), and
oppositional defiant disorders (11%). However, the majority of caregivers and children
scored in the normative range on the symptom questionnaires on emotional and
behavioral functioning. None of the demographic or child health variables or measures
of caregiver’s mental health was significantly associated with the presence of a child

psychiatric disorder. There was an association between caregiver’s mental health and the
child’s emotional and behavioral conduct. The authors recommended that mental health
interventions be integrated into medical care to help members of this vulnerable

population to optimize their health and well being.

2O

Psychiatric Hospitalizations Among Children and Youths with HIV/AIDS

Children with HIV/AIDS are at an increased risk for psychiatric hospitalizations

during childhood and early adolescence compared with the general pediatric population

(Gaughan et al. 2004). The Pediatric AIDS Clinical Trials Group examined long-term
outcomes among HIV-infected children and HIV-uninfected infants born to HIV-infected
women.

Children with HIV infection were examined quarterly and laboratory data

collected. Hospitalizations and diagnoses for all participants between September 2000
and December 2002 were reviewed. Among 1808 HIV-infected participants who were

less than 15 years of age at the last visit date, 25 children had been hospitalized for

psychiatric manifestations, 8 before enrollment in the study, 17 after entry into the study,
which represent an incidence of 6.17 cases per 1000 person-years. This was significantly

higher than the incidence of 1.70 cases per 1000 person-years in the general pediatric
population less than 15 years of age, as reported in the 2000 National Hospital Discharge

Survey, yielding a relative rate of 3.62. A total of 32 HIV-infected children, regardless of
age, were hospitalized because of psychiatric illnesses. The majority of patients were
admitted because of depression (n

16) or behavioral disorders (n

8). Fifteen (47%)

underwent multiple psychiatric hospitalizations. The median age at the first psychiatric

hospitalization was 11 years (range: 4-17 years); all patients had been perinatally
infected. Knowledge of HIV positive status and having experienced a significant life
event were both significantly associated with an increased risk of psychiatric

hospitalization. No psychiatric hospitalizations were observed among the 1021 non-HIV
infected members of the cohort.
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Other Barriers to Adherence

Many studies have proven the efficacy of HAART slowing the progression of
HIV to AIDS and prolonging the life of people that live with the virus. However, almost
perfect adherence to medication regimes is needed to maintain optimum results. HAART
can achieve undetectable plasma levels of the HIV virus, but if taken sporadically, the

virus can become resistance to the drugs, making them permanently ineffective

(Futterman et al. 1999). However, the realities of achieving adherence to medication in
adolescents given their developmental stages, cognitive and behavioral issues challenge
the likelihood of successful adherence to HAART. Medical and ancillary services need
to pay attention to many possible problems that can be associated with the lack of

adherence.

The interruption of medication and its effects on the progression of the disease are
constant concerns of clinicians. There are not many studies on the matter but the one

done at the Milano University in Italy (d’arminio M. et al. 2005) gives food for thought
on the matter. Although this study was done on adults’ interruption of medication, it is
an issue that has relevance in adolescent adherence. They investigated the frequency of a

first therapy interruption (TI) at 12 weeks or more after first starting the medication.

Researchers wanted to identify the factors associated with TI and with therapy

resumption, and to compare the risk of developing clinical events during TI and during
continuous therapy. Three thousand one hundred forty two patients who started a first

HAART regimen participated in the study. The main reasons for TI were patient’s
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decisions (47.4%) and toxicity (24.0%). Women, injection drug users, and patients with
a higher current CD4 cell count were more likely to interrupt. The median time to

therapy resumption was 12 months. The higher the current CD4 count, the slower was
the rate of resuming therapy; conversely, patients who stopped because of medication
failure and those with a pre-HAART viral load more than 100,000 copies/mL resumed

therapy sooner. Two hundred eighty-one patients experienced clinical progression at a
rate of 2.6 per 100 person-years (pys) while patients who were on therapy had a 3.5 per

100 pys during TI.

This study concluded that TI occurring in clinical practice is

associated with an increased risk of clinical progression; hence, therapy interruption

should be discouraged if it is not suggested by the clinician.

Adipose tissue alterations (ATA), which are common among persons treated with

highly active antiretroviral therapy (HAART), can have substantial psychological
repercussions, with a subsequent negative impact on the person’s quality of life and on

HAART adherence. This factor has a devastating impact when occurring in adolescent
patients who are in the developmental stage in which image is an important issue in their
lives. Ammassari et al. (2002) evaluated the longitudinal relationship between ATA and

adherence to HAART. Even though these studies were for adults and the cross-sectional
nature of the studies preclude establishing the direction and causality of the relationship,

they give a perspective on one of the problems that could affect adherence in adolescents.
The analysis included all participants in the AdICoNA and the LipolCoNA substudies of

the Italian Cohort Naive Antiretrovirals (ICoNA). Adherence was assessed using a 16item self-administered questionnaire that also included a question on self-perceived fat

23

accumulation experienced during the past 4 weeks. ATA was diagnosed by physicians at

enrollment and evaluated every 6 months thereafter. There were 207 patients with a
median age of 35 years; 73% were men; 34% acquired HIV through injection drug use.

At baseline, non-adherence was reported by 63% of the participants, and ATA was selfperceived by 15% and clinically diagnosed in 25% of the cases. Patients with good
adherence at baseline were more likely to develop ATA and developed it sooner. Self-

perceived ATA at baseline was independently related to subsequent non-adherence, but
clinically diagnosed ATA was not related to non-adherence.

Patients’ adherence to

HAART is a dynamic process that interacts with ATA. Better adherence was associated
with a higher risk of subsequent occurrence of ATA while patient-perceived onset of

morphologic alterations can reduce adherence to antiretroviral therapy.

Depression symptoms and disorders in adolescents are often under identified and
under treated (Reynolds, 1994).

Many studies have found an association between

depression and the lack of adherence to medications. If the severity or the duration of

depression episodes could be decreased maybe adherence can be improved. Murphy et
al. (2005) at the Health Risk Reduction Projects, Department of Psychiatry, University of

Califomia, followed a cohort of adolescents with HIV to investigate long-term
antiretroviral therapy adherence and factors associated with adherence. The strongest and
most consistent finding in this study was the relationship between depression and non-

adherence. Two hundred and thirty one adolescents infected with HIV with mean age of
18.4 years; 72.7% female; 74.9% African American from 13 cities throughout the United

States were assessed at 3-month intervals. At the initial visit, approximately 69% of the
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adolescents reported adhering to the medications. Adolescents in the late stage of the
disease were found less likely to be adherent compared with those in the earlier disease

stage. Less alcohol use and being in school were associated with adherence. Also,

longitudinal adherence was investigated among 65 subjects initially adherent with
available information for at least 4 consecutive visits. The median time to non-adherence
was 12 months and failure to maintain adherence was significantly associated with the

younger age and depression. Among adolescents who attained an undetectable viral load,

only about 50% maintained an undetectable viral load for the year. The researchers
advise that new treatments for adolescent depression may assist in improving adherence

for a majority of adolescents with HIV.

As illustrated above, there are many factors that could impede positive adherence
to HIV medications for adolescents.

Trocme et al. (2002) in France examined the

question: Is poor treatment adherence, frequently observed in the HIV positive adolescent

population, due to the adolescent’s developmental process, their experiences while living
with HIV, or their lack of information about the disease or treatment? Researchers
interviewed 29 HIV positive adolescents in one pediatric reference center. Confidential

interviews were performed according to a standard questionnaire. They found that 70%

had stopped taking their medications at least once since starting treatment. Adolescents
stated that treatment was the major barrier to their sense of freedom. One-third of them
decided to stop it for more than one month. Seventy percent had good information about
their sickness and the potential consequences. Fifty-five percent expressed feelings of
loneliness or depression, yet 75% considered they had a pleasant life because they had a
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normal life. Researchers attributed this fact to the secrecy and silence about their HIV
condition. The authors concluded that being dependent upon a treatment is a major
constraint in the lives of HIV positive adolescents. Although adolescents were fully

informed, the deliberate interruption of treatment could attest to their expressed need for

autonomy.

Also, in a factor analysis of the barriers to adherence to HAART therapy among
HIV-infected adolescents done through the REACH project (Murphy et al. 2003), it

showed that there are two factors accounting for the largest proportion variance in
adherence: (1) medication-related adverse effects (both physical and psychological) and

(2) complications in day-to-day routine and the adolescent’s life style, busy schedules,
medication interference with their activities, lack of support from a dysfunctional family,

homelessness. In this study, adherence was tied closely with daily routines and supports
the assumption that working closely with adolescents to improve their organizational
skills is necessary to improve adherence and provider-level intervention is needed.

Approaches to Enhance Adolescent Adherence to Medications

Several approaches have been used among the community of providers with the

goal of providing better health care and motivating youth to maintain adherence to their
medications. As Simone et al. (2003) stated, "Adherence has been proven to be the
Achilles’ heel".

Simone’s group analyzed the antiretroviral therapy adherence

intervention studies published through January 2003. In the 21 studies published up to
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2003, four interventions were identified, although all of them were for adults that could
very well be used with adolescents: cognitive-behavioral, behavioral, directly observed

therapy and affective therapy. Another four randomized controlled trials suggested
promising effects: pharmacist-led individualized intervention, cognitive-behavioral,
educational interventions based on self efficacy theory, and cue dose training when
combined with monetary incentives. Another 39 federally funded studies offer better

methodological sophistication and include new strategies, such as the use of handheld
devices, two-way pagers and alarm medication vials. To our knowledge there are no
publications on the effectiveness of these devices, or their long-term efficacy.

Providers serving adolescents who aimed to improve adherence and therefore the

health and survival of HIV infected people, have developed some models that can be

helpful. A family group approach to increasing adherence to therapy in HIV-infected
youth was studied at the Division of Adolescent and Young Adult Medicine/Burgess
Clinic Children’s National Medical Center (CNMC) in Washington, DC. Lyon et al.

(2003) describes the development of a novel, pilot program in which a combined family
group and peer approach was used to increase adherence to antiretroviral therapy in HIVinfected youths. Twenty-three HIV-positive youths, 15-22 years of age and 23 family

members or "treatment buddies" participated in one of three 12-week programs. The
intervention had six biweekly family/youth education sessions and six biweekly youth-

only education sessions. Devices to increase adherence to antiretroviral therapy such as
pillboxes, calendars, and watch alarms were introduced at youth-only sessions. Eighteen
of the 23 youths completed a group. Ninety-one percent of the youths self-reported
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increased adherence to medications after completion of a group.

Four participants

experienced reduction in viral loads to undetectable levels during the intervention. Two

participants continued to decline antiretroviral medications at the end of the intervention
and demonstrated no decrease in viral load. Participants tested five devices and rated the

multiple alarm watch as the best aid for improving adherence to medication.

Family/treatment buddies rated the overall program as highly helpful, citing social
support as most valuable. An unanticipated benefit was an increase in other health

behaviors, including medical and dental appointments, hepatitis B and influenza
immunizations, and referrals to mental health and substance abuse treatment.

The need to integrate mental health and primary care service delivery for
adolescents living with HIV/AIDS has been documented in the description of NOAH (No

One Alone with HIV) program. Accessibility, flexibility, and cultural specificity are
qualities necessary, but generally lacking, in existing models of integrated care. Feingold
et al.

(1993) describes NOAH at the Boston General Hospital of Psychiatry. This is an

innovative, hospital-based program of family-focused HIV mental health services.

NOAH is designed to meet the needs of primary care providers, allied
professionals/paraprofessionals, and the diversity of inner-city patients they serve.
Central to the model are population-specific "family health facilitators," who collaborate
with providers by offering mental health interventions at one or more levels along a
continuum of service intensity. Whenever possible, primary care team members are

empowered to manage mental health problems directly. When more intensive services
are required, responsibility for direct intervention transfers to the family health facilitator.
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With the locus of inner-city HIV primary care shifting from hospitals to neighborhood

health centers, this hospital-based program has been extended into the community to

support the early integration of mental health and primary care services at the community
level.

Based on the belief that integration of services can lead to improvement in
treatment adherence, and with a considerable number of HIV positive adolescents and

young people presenting issues with co-occurrence of mental health and substance abuse,
the need to provide integrated care is gaining prominence. Some evaluations of programs

sponsored by the Ryan White Comprehensive AIDS Resource Emergency Care Act were
published in AIDS CARE 2002. The descriptive evaluation data for one of the Center’s
model of multidisciplinary HIV care showed that people living with HIV, who received
case management, mental health, chemical dependency services, and transportation co-

located with primary care were significantly more likely to receive regular HIV and

primary care (Sherer et al. 2002).

The model featured one-stop shopping service

delivery. Available on-site services included integrated services for women, children and

families, health education, HIV testing and counseling and direct links with public and
social services.

Beliaeva et al. (2003) in Russia studied approaches to enhancing adherence of
HIV-infected patients receiving antiretrovirus therapy. Twenty-five patients (including 3

females) aged 18 to 45 years receiving VAART (fortovasa + norvir + videx, and
viramun) were examined. During treatment, group classes were conducted to enhance
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patient adherence to the therapy and were followed by individual counseling in order to
consolidate the obtained effect. The adherence to the therapy was rated by the patients’

self-reports. There was an increase in the activity and openness of those who attended
group classes and positive changes were seen in their self-assessment. Approaches to
enhancing adherence and a model school for HIV-infected individuals were developed.

It was shown that a combination of patients’ awareness of different HIV-infectionassociated problems with counseling allows treatment motivation to be increased.

A project derived from lessons learned from the Special Projects of National
Significance Program, a study done in several sites, describes a model whose focus is to
enroll youth with HIV into care through new or existing HIV service networks, and direct
recruitment via street outreach and other similar methods. At both the national and local

levels there are five major elements that capture the innovations of the collective service
method: (a) peer-youth information and dissemination; (b) peer-youth advisory groups;

(c) peer-youth outreach and support; (d) professional, tightly linked medical social
support networks; and (e) active case management and advocacy for individual clients as
well as the programs themselves, to link the various components together. One of the
most important factors in the model leading to success is that youth and professionals

share an equal partnership in all stages of program design, planning, and implementation.
Youth and professionals each share their expertise in a dynamic process. In addition,
active case management is crucial; not only to ensure that clients receive needed services,

but also to ensure that the programs themselves run in a coordinated, tightly linked way.
Given needs of adolescent clients and existing adult-oriented service networks, the use of
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active case management and the active participation of youth in the service systems are
critical.

The above background review gives a broad picture of the numerous elements
that depict medication adherence in adolescents from different perspectives. There are

abundant studies that encompass relevant issues from pediatric to adulthood that affect
adherence in adolescents. Starting from the first pediatric cases to the current HIV

positive adolescent population, the programs review issues such as: disease progression;
medication benefits; family dynamics; cognitive, behavioral, mental health issues and

models of practice. The following study tries to assess some of those elements at the
UCHC/CCMC HIV Pediatric and Youth program.

Chapter 3: Methodology

The UCHC/CCMC Pediatric and Youth HIV Program first began providing

pediatric HIV research care and family support services under the auspices of the

University of Connecticut Health Center (UCHC) Pediatric HIV Program in 1989. The

approach to care is child/youth centered and family focused because of children’s nearly

complete dependence on their caregivers as well as the two generational (mother and
child infected) aspect of pediatric HIV. The program provides HIV medical care and

research as well as support services. There are two weekly clinics to monitor the HIV
related issues of the infected children and youth and to test newborns of HIV infected
mothers.

Another weekly clinic carries out the clinical research and two bi-monthly
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clinics offer families the opportunity of the parent and child being seen by their HIV

specialist in only one visit. A unit of five social workers makes available an array of
services such as: case management, support groups, mental health counseling, prevention
education and HIV counseling and testing. The program is the primary provider of

pediatric and adolescent HIV care for Hartford, Tolland and Middlesex Counties and
serves over 184 clients including some of the parents and siblings of HIV positive

children and youth.

As the children in the program grow into puberty and adolescence, there is the
need to learn more about the issues and social needs relevant to development and

specifically how this affects adherence to the HIV medications. This was a descriptive

study of 30 HIV positive youth that attend the UCHC/CCMC Pediatric, Adolescent and
Mother/Child Clinics. The specific aims for this study were medication adherence and

the factors related to family, peer and community support, services used by the

adolescent/family, cognitive, emotional and behavioral problems and the relationship
between the adolescent’s knowledge of medication and health status and adherence. The

dependent variable was adherence to HIV medications obtained through the measurement
of HIV RNA levels and CD4 counts. Three domains were measured as independent
variables: family support and community involvement with the family; adolescent

development (physical, cognitive, emotional and social); and adolescent knowledge of

HIV medications and their benefits and trust in medical providers.
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Sample

The sample was taken from the program’s 184 clients, excluding anyone not

positive or not between the ages of 13 to 24 years old. The study was thus offered to HIV
positive patients ages 13 to 24 attending the clinics. Thirty-six clients were recruited at
the initiation of the study.

Completed data were collected on 30 participants; one

adolescent died, 3 moved out of the area and 2 transitioned to adult care. This study took

place from January to December 2005. There were 16 female and 14 male participants.
The majority of them were minorities: 56.7% Hispanic, 20% African-American, 13.3%
White and 10% mixed heritage. Fourteen of the adolescents lived in Hartford, 5 in New

Britain, 3 in West Hartford, 2 in East Hartford and the other 6 lived in small towns in the
Northeast region of Connecticut. Approval from the CCMC Institutional Review Board
was obtained. Written consent forms were signed by each of the participants.

Data Collection

An unstructured interview to define the content of the domains to be associated
with the adherence was piloted with 10 patients and their families at the Yale University

HIV Pediatric Program. Information from these interviews was used to develop a
structured survey that was administered to the UCONN/CCMC patients who consented to

participate in the study. The survey was administered to each youth privately by the
trained social services team that kept in mind the adolescent’s developmental age and
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appropriateness of cognitive level.

When needed, the social worker explained the

meaning of the question in order for the adolescent to give the most informed response.

In addition to the structured questionnaire data was collected from record review
(medical and social services). Quantitative data regarding levels of CD4 and viral load
counts were collected through the medical record review. Disease classification was

measured according to CD4 clinical classification (MMWR 1992) for levels of

suppression. Levels of suppression were based on the following categories" category 1

"no suppression" equal to > 500 CD4; category 2 "moderate suppression" equal to 200 to
499 CD4 and category 3 "severe suppression" equal to or less than 200 CD4 count.

The family support domain was measured through a number of variables that
define the family’s dynamics, such

as"

youth that have a biological parent alive,

parent/caregiver’s education, household members, exposure to substance abuse and
violence, and whether family/caregiver was ever incarcerated. Community support was
obtained by measuring the number of community agencies the adolescent/family has used

including the Department of Children and Families (DCF) involvement with the family.

Measurements for the medical domain were geared to obtain the level of
adherence. Measurements were taken

on"

adolescents’ knowledge of medications they

were taking, number of doses missed in the last two weeks, knowledge of the relationship

between lab results and the medication taken, who was responsible for administering the
medication (themselves or caregiver) and reasons for missing medications.
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Eight

parameters were given to the subject to choose in this variable: forgot, slept through,

away from home, side effects, depressed, reminded me I am HIV, concern with

disclosure, and don’t feel sick. The developmental domain had three variables: cognitive,
emotional and behavioral. To measure cognitive development, factors such as special

education and appropriate school grade were included.

The emotional variable was

evaluated by asking the youth several questions: Were you ever abused (physically,

sexually or emotionally)?. Have you felt depressed in the last month?. Have you thought
about running away?. Have you had suicidal thoughts?. Have you tried to commit
suicide?.

For the behavioral variable, factors taken into account

were"

problems in

school, court involvement, sexual involvement and use of substances.

Chapter 4: Results

Demographics

Participants in the study included: 16 females and 14 males, the majority of them
were minorities: 56.7%

(18) Hispanic, 20% (5) African-American, 13.3% (4) White and

10% (3) were of mixed heritage. For many, HIV is not their main concern since issues of

poverty keep them struggling to survive. Sixty percent, (18) families in the study had an
income of less than $20,000 a year and their main sources of income were: 23% (7)

employment, 37% (11) government and 40% (12) a combination of employment and
government subsidy. As a result, families used community resources, especially the

Ryan White Care Act network of agencies that provide emergency financial assistance
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such as subsides for rental housing, transportation, utility bills, medical and dental bills,

food vouchers, mental health and substance abuse programs. All the families except ten

percem (3) used these Ryan White services.

Levels of infection

At the time of the study, 73% of the youth were category 1 with CD4 counts over
500 cells, 16.7% were category 2 with CD4 counts 500 to 200 cells and 10% were

category 3 with CD4 counts under 200. Regarding viral load, 30% were undetectable,

13.3% had counts between 200 to 1,000 copies and 43.4% had less than 20,000. Only
one youth had over 100,000 copies at the time this variable was documented.

Evolution of Family Dynamics

In the beginning of the AIDS epidemic most parents died before their infected
children, so the children used to live with grandparents or relatives. Today’s scene for the
adolescents is different. Even though 73% (22) of youth in the study still had biological

parents alive, only half of them, 11, lived with their parents and of those, only 4 lived
with both parents and 7 with a single parent. Some of these families struggle to do good,

especially those whose parents are recovering drug addicts and still provide stable homes.

However, for others living with biological parents, their situation has not guaranteed a
better life for them. Four of them have been involved with DCF, six had to deal with

dysfunctional families, and four have addicted or recuperated parents. All but one has
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seen their parents dealing with their own disease. Among the 63% (19) of the youth not

living with biological parents, 32% (6) were adopted through DCF as children and only
three of them still live with the adopting parents. Seventeen percent cent (5), all females,
had established their own homes, another 10% (3) were transient, one was living in a

shelter, one was living with friends and another ended up in DCF custody and has been in
different foster homes. Another 16.7% (5) were in juvenile detention or mental health

programs. Two of them were in mental institutions due to the traumatic experiences they

experienced during childhood and three were in detention at the time of the study. Below
is one story (cases in this study have been taken from social services records and names
are pseudonyms)"

Mafia, whose mother died when she was a baby, lived with an aunt
until she was thirteen. As a teenager she started to have friction with

her aunt because of the limitations the aunt was imposing.

Looking

for a way out, she went to live with her father, who up to this time was
not very involved with her. During the time she was with the father,

she did not receive any support or attention from him or his girlfriend.

On the contrary, while staying at the father’s house she did not take
her medication, did very badly in school and lacked the basics because
he was taking her social security benefits. Depressed and rebellious,

she left her father’s house to live with another aunt. This arrangement
did not last long because of her behavior and sexual activity. After she
was asked to leave the aunt’s house, she was homeless and pregnant

and living with friends. Today she is dealing alone with the issues of
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her pregnancy and medication adherence in order to avoid
transmission of the HIV vires to her baby.

Mental Health

The mental health issues in this group of adolescents are significant. They face

depression, anxiety, denial and rebellion issues that may interfere with adherence. Youth
in the study have experienced a lifetime of traumatic events that are manifested in

symptoms such as aggression, lack of trust, lack of interest, lack of social skills, truancy,
depression, runaways, suicidal thoughts and suicidal attempts. In spite of the fact that

80% (24) of the adolescents have shown emotional problems and signs of mental
disorders, only 33.3% (10) have been diagnosed and even fewer have received
professional help. Sixty seven percent (20) of youth in the study have witnessed violent
acts in their homes or neighborhoods and 63% (19) have been involved in a fight. Sixty

percent (16) of them have been exposed to the change of different foster homes or

institutions, or have seen their parents frequently changing partners. For many of the
children and youth, the medical providers and case managers have been the most
consistent figures in their lives. These life experiences cause major problems for the

youth when they deal with issues of trust. Trust in HIV infected adolescents is very
much attached to the issue of confidentiality about their HIV status and is one of the
reasons for them to be isolated socially.
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Another parameter used to measure mental health was abuse, whether physical,
emotional or sexual. Although 30% (9) did not consider themselves abused, 58% thought
their caregivers emotionally abused them.
measure appropriately.

Emotional abuse is a complex factor to

Due to the adolescents developmental stage in which they

struggle for their independence, restrictions from parents or caregivers could be perceived
as abuse. Although some of the youth showed signs of the possibility of being sexually

abused as children, only two cases were confirmed.

Depression in young people is associated with poor academic performance, social

dysfunction, substance abuse, and suicidal attempts. Depression in this group of youth
comes from issues of their family life, coping with their disease or

parents’ disease,

problems at home or school or with their peers. Fifty-seven percent (15) of the studied
youth reported being depressed. When they were asked for the reasons for their sadness,
26.7% (8) said problems in the family; 20% (6) being sick or parent being sick; 20% (6)

discrimination, 16% (5) missing their biological parents; and 6.7% (2) worried about the
future. Fifty percent said they shared their feelings with their parents or a member of
their family when they felt sad while 33.3% (10) said they talked with no one and that

they tried to "tough it up" by isolating themselves, listening to music or trying to sleep.
Only 13.3% (4) shared their sadness with a friend, usually their partner. And while most
reported having friends, when it came to having support because of their HIV condition,
only 26% (8) said they have one or two friends that knew about and could talk to them
about it. They try to internalize their feelings regarding their condition and prefer not to
talk about it because it is very painful.
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Another way depression was expressed was through suicidal thoughts or attempts;

23.3% (7) have had suicidal thoughts and two of these attempted suicide. The following
two case studies illustrate the often dire situations that these youngsters face"

Joyce was removed from her home at the age of 9 because of alleged
sexual abuse by one of the family members. She lived in different
homes and because of a suicidal attempt ended up in a mental facility.
This institution has been providing therapy and working with her in

finding a foster home or reunification with her mother. She has not
been able to work out her own feelings.

It seems that her fears

interfere with an ability to achieve a more stable living arrangement.

On the other hand, it also appears that she wants to be in the institution
because it has been the one place that has given her the most consistent

support.

Charles, a 16 year old young man in detention, spent a life of
desperation with his mother’s erratic behavior.

She used drugs,

engaged in prostitution, had two HIV infected children and finally
committed a dramatic suicide which he witnessed. After this traumatic

event, he got in trouble with the law and was detained. When the court
wanted to send him home, his grandmother rejected him and he was
sent to a detention institution. He has been under DCF custody since

then. Although his parole officer, DCF and hospital social workers
advised him to stay with DCF in an alternative home, he looks forward
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to living with his sister, who does not offer much safety since she is

also HIV positive and is bipolar and cannot offer him much stability.

Disclosure of the HIV diagnosis is very difficult and in many cases can cause

many emotional problems because of the stigma attached to the disease.

Even though

the majority of the adolescents in the study acquired the disease through their mothers,
the stigma is still very much present in their lives. For these adolescents, stigma plays a

role in keeping their HIV status secret, as do their fears about being treated differently at
an age when they just want to be part of a group.

Joanne’s fears about disclosing her diagnosis were so intense that she
dropped out of school after she told the principal and nurse about her

HIV status. She had been encouraged to disclose by the program staff
because she was not taking her medications and the school nurse could

give them to her. After dropping out of school, she continued not

taking her medications and got involved with drugs.

One of the

reasons why she dropped school was the fear she would lose her

friends, but the school counselor and her school friends were at her
bedside at the hospital when she died.

Cognitive Impairments

Cognitive level is a very important issue related to adolescent medication
adherence. The HIV virus can attack cells in the brain leading to damage of the central
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nervous system. Studies have tried to assess HIV impact on cognitive, neurological and

behavioral functioning or neuropsychological functioning (see chapter 2). The pathology

of neuropsychological deficits in children and youth with HIV is difficult to ascertain

because these deficits may be associated with factors other than HIV including prenatal

drug exposure, low level of parents/caregivers’ education, discordant mother/child
interaction, poverty and other developmental issues.

Difficulties with short-term memory, vocabulary deficiency and comprehension

of simple statements have been identified as neuropsychological symptoms. Assessing

the cognitive functioning of youth in this study through neuropsychological testing was
not possible because of the lack of financial resources to perform this test on each

participant. Other indicators used as proxies included: involvement in special education
and appropriateness of school grade and age and school dropouts. Half of the youth in

the study qualified for special education. Because of the complex process for youth to be
identified as a student with special needs for education, this may under report the actual

need for special education. When one compares the current grade level of the youth to
the age appropriate norms, 40% (12) were at normal grades or graduated from high

school at normal age level, although one of them was socially promoted. Twenty-seven

percent, 8, of the youth were one year behind, 10% (3) were two years behind, 3.3% (1)
was more than 3 years behind. Twenty percent (6) had dropped out of school. Everyone

who dropped out was female; all but one of these had become pregnant and could not
maintain schoolwork and motherhood. For these young mothers, the lack of education
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put them at a disadvantage in properly raising their children and obtaining jobs that could
sustain them financially.

Criminal Justice Factors

A high rate of interaction with the judicial system was observed, especially for the
males. Forty-eight percent (14) had had problems in the school such as: skipping classes,

fighting, defiant behavior and carrying knives. When they are charged with any of these
offenses before age 16, they go to court and sometimes end up in juvenile detention for a
short time. Usually the charges are for truancy or breach of peace. If they accumulate
new charges and are still under 16, they go to juvenile detention for a longer period at the

Connecticut Junior Republic. Since Connecticut is one of three states that treats youth 16

years and older as adults, at this age they are treated as adults and end up in jail. More
than half of the youth in the study have had problems with the justice system; 26.7% (8)
had been in court and another 26.7% (8) had been detained. Forty percent (12) of the

youth had smoked marijuana and one of them was using hard drugs. There are many
conditions that promote unlawful behavioral problems for these youth. Seventy-three

percent, 22, of the youth in the study have been exposed to substance abuse or selling

drugs. Fifty percent of their family members or caregivers have been incarcerated.

The family’s financial situation is another problem that puts these youth at risk for
criminal activities. Some of them have been adopted or live with relatives and some are

subsidized by DCF or social security. The subsidy has presented a problem in some of
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these families because when youth reach 18 and are not in school, the financial assistance
to the family is terminated. Lacking this support makes it more difficult for the families

and so some of these youth have been asked to leave their homes:

Fulano, a 18 year old who is adopted, was put out of his house as soon
as the financial assistance was cut.

Since then, he has been in

temporary shelters. He was put in jail because he had stolen some
items in a store and damaged some cars. His resilience and the work

of his case manger have helped him to survive eight months of

homelessness and emotional distress.

In spite of the traumatic events they have experienced with their families, family ties are
very important:

Pablo, who lived with his grandmother, was in detention for truancy.

He stole a car from the detention to go to see his elderly grandmother
because he was concerned about her because she has cancer. His

grandmother has been his main caregiver because his mother has spent
most of her life using drugs or in jail.

Sexual Behavior

The sexual activity of the HIV infected youth was found to be similar to that of
the national picture. A trend seen in the study was that HIV positive youth engaged in

early sexual activity. Fifty percent (15) were sexually active at the time of the study and
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12 of these were female. Four of the females were infected through sex at a very early

age. Some of the adolescents have shown very aggressive sexual behavior, going on
sexual experimenting rampages. For two of them, an underlining mental issue such as

bipolar disorder contributed to this behavior.

In spite of the program’s constant sexuality education to prevent these adolescents
from transmitting the infection, only one youth said she had always used condoms, while

14 reported using condoms only sometimes. One reported having one partner, two had
over 20 and 12 had between 5 and 10 partners.

For female adolescents, pregnancy

further complicates the existing challenges of poverty, traumatic experiences, poor social

support, adolescent development stages and mental disorders. Eight of the 12 sexually
active female youth have children but only two children were HIV infected. They were

born before 1996 and the establishment of the AZT protocol to prevent the maternal child
transmission of HIV. Early sexual activity often results in pregnancy and they are not

able to maintain schoolwork and motherhood. One of them initiated sexual activity at the

age of nine, had her first baby at 12 and her second at 15. This aggravated the girl’s
home situation where the mother is also HIV positive and has two young children as well
as raising three grandchildren, her daughter’s two and another one from her oldest son.

The transmission of HIV to others is a serious issue. It is not only about HIV

positive adolescems’ sexuality and how they perceive it; it is also a public health issue.

A big factor is disclosure. If teens are able to disclose, they may be able to negotiate the
use of condoms with their partners. Seven of the fifteen sexually active adolescents had
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disclosed their HIV diagnosis to their partners. Eight had not told their partners about
their HIV status.

Adherence to Medication

Adherence to medication directly affects HIV status. Adherence for this study
was defined as the proportion of prescribed medications taken to the missed doses in a

two-week period. For the analysis, four adolescents who were not taking medication and
5 that were in institutions were not included.

For the remanding 21, the median

adherence was 89%. This cohort was divided using the median into high adherence (11

youth and low adherence 10 youth).

Medication adherence was examined by

demographic characteristics, psychosocial factors and medical issues. Most comparisons
were not statistical significant, though some trends were present. The small sample size

provided limited power to explore correlations.

There were more males than females in this cohort and Hispanics were 57% of
the participants. In the low adherence group, more parents/caregivers had not graduated

from high school (57.1%) compared to parents/caregivers in the high adherence group

(42.9%). Also, families in the low adherence group have had more involvement with
DCF (58.3%) than the families with no DCF involvement (33.3%). Income was low for
most of the families in both groups with few families earning more than $30,000 dollars a

year.
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Table 1. Percentage of Youth not in Institutions Taking Medication by

Demographic Characteristics by Adherence.
Characteristics
Gender
Male
Female

Race
Hispanic
African American
Caucasian
Mix Heritage

N

High adherence

Low adherence

11
10

54.5%
50%

45.5%
50%

12
3
3

75%
0%
66%
O%

25%
100%
33.3%
100%

Parent/Caregiver education
Not graduated from high school
Graduate from high school

14

42.9%
57.1%

57.1%
42.9%

Family DCF involvement
Yes
No

12
9

41.7%
66.7%

58.3%
33.3%

Annual income
<30,000
30,000 +

16
5

50%
60%

50%
40%

As the literature revealed, (Shanbhag 2005, Jeremy 2005, Nozyce 2006) of those
with cognitive problems, as measured by school appropriate grade level, 72% had low

adherence (Fisher exact, p= .030). A trend was found in youth witnessing violence where
the high adherence group had a higher percentage with 66.7% (Fisher exact, p

.198).

Although the impact of family support was not statistically significant, those adolescents
who were transient or living by themselves had low adherence, with 60% of them in the
low adherence group. Regarding mental health, also mentioned in the literature review

(Mellins 2006, Gaughan 2004), two of the participants were hospitalized for psychiatric
disorders before the recruitment. Depression was higher in the low adherence group
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(=12.982, p= .024); 60% in the group self-reported depression, compared to 40% in the
high adherence group. Half of the study participants in both adherence groups had
emotional problems, largely determined through chart review. More sexually active

youth were in the high adherence group (62.5%) than in low adherence group. More

youth in the low adherence group (55.6%) had been involved with the judicial system.
Substance abuse, especially marijuana, was higher in the low adherence group (66.7%)
than in the high adherence group. Youth in the high adherence group also had more
friends that knew about their HIV status (66.7%).
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Table 2.

Percentage of Youth, no in Institutions, Taking Medication by

Psychosocial Factors by Adherence

,Psychosocial Factors

N

High adherence Low adherence

11
10

27.3%
80%

72.7%
20%

12
9

66.7%
33.3%

33.3%
66.7%

5
16

40%
56.3%

60%
43.8%

10
11

4O%
63.6%

60%
36.4%

16
5

50%
60%

50%
40%

13

62.5%
46.2%

37.5%
53.8%

12

44.4%
58.3%

55.6%
41.7%

6
15

33.3%
60%

66.7%
40%

Have friend that know about diagnosis
Yes
No
15

66.7%
46.7%

33.3%
53.3%

Cognitive problems
Problems

No problems
Witness violence

Yes
No

Living arrangements
Self and homeless
With parents/caregivers

Depression
No
Emotional problems

Yes
No

Sexually active
Yes
No
Involved with judicial system

No
Substance abuse

Yes
No
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Concerning the medical issues, the high adherence group was more likely to have

high CD4 counts than the low adherence group

(- .130 and P .192). Reasons for not

taking the medication was significant (g=12.982, p= .003). All those with "family

problems" were in the low adherence group, while all those that "slept through" were in
the high adherence group. Being"depressed" and "forgetting" to take the medication
were the same in both groups. As for viral load count, more of those with undetectable
amounts were in the high adherence group (80%).

There were more youth who

understood the relationship between laboratory results and medication adherence in the

high adherence group (62.5%). While only 50% of those not responsible for taking their
medications were in the high adherence group, 81.8% were in the low adherence group

(Table 3).

In general, this group of HIV+ adolescents is healthy. Only 3 youth were
hospitalized during the research period, two in the high adherence group to deliver babies
and one in the low adherence group for HIV related issues. In the low adherence group 3

youth went to the emergency room, one for treatment because of a car accident and two
for HIV related issues. Regarding clinical visits missed, one missed one appointment and
another missed two appointments in the high adherence group. In comparison, 8 youth
missed clinical visits in the low adherence group, including 4 youth that missed one

appointment, one that missed two appointments; two that missed three and one that
missed more than four appointments.
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Table 3. Percentage of Youth, not in Institutions, Taking Medication by Medical

Issues by Adherence
Medical Issue"

N

High adherence

Low adherence

CD4 counts
<200
200+

2
19

0%
57.9%

100%
42.1%

3
4

O%
50%
100%
50%

100%
5O%
O%
5O%

80%
4O%
67%
67%

2O%
6O%
33%
33%

13

62.5%
46.2.2%

37.5.3%
43.7

11
4

81.8%
50%

18.2%
50%

Reason for not taking medication
Family problems
Depression
Slept through

Forgot
Viral load count
Undetectable

1,000 10,000 copies
10,000-20,000
20,000-50,000

5
10

Understand lab/adherence relationship

No
Responsible for taking medication
Yes
No

In summary, the factors associated with high and low adherence in this sample of
21 youth were consistent with the issues demonstrated in the literature review. Youth not

adherent to medication have problems in the areas of cognition and mental health and
have less family and peer support. Youth in the high adherence group had better CD4
and viral load counts, less cognitive deficiencies, and better family support. Unexpected
was finding that more youth in the high adherence group were exposed to violence. Also,

youth in the high adherence group were more sexually active.
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Programmatic Services

The University of Connecticut Health Center and the Connecticut Children’s
Medical Program (UCHC/CCMC) is the main HIV program in the northeast part of the

State. The program strives to provide integrated care in one place and delineate ways to
facilitate provider collaboration. A multidisciplinary team of doctors, nurses, dental

hygienist, nutritionist and social workers see the patient during a clinic visit. Because the
clinics take place at the children’s hospital, primary care including gynecology and many

other services can be offered in the same place. For the pregnant adolescents, services
are offered at the Women’s Health Center at Hartford Hospital located on the same

campus.

The social services unit is funded in large part by the Ryan White Care Act and
consists of five social workers that make available an array of services such as:

psychosocial support, case management, support groups, mental health counseling,

secondary prevention education and HIV counseling and testing. The program is the
primary provider of pediatric and adolescent HIV care for Hartford, Tolland and
Middlesex counties and serves over 184 clients.

The program works closely with the Department of Children and Families (DCF).

Sixty percent (18) of the families had been involved with DCF and in most cases received
services from the agency. Although not all the services are the result of punitive action,
families usually fear this agency’s intervention because it could mean family separation,
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with the children going into foster homes or institutions. However, this agency has an

array of programs that eventually can help the children and youth and it is very difficult
for families outside of the system to obtain these services. The problem with this system
is that their preventive services are mostly ineffective until the youth are committed to the

State. Also, the system allows the youth to refuse services when they reach 16 years of
age.

Although the program tries to provide comprehensive care, because of financial
constraints, it lacks a mental health component that could provide neuropsychological

testing for every youth or psychiatric assessment and long-term therapy so that many of
the mental health problems would not go undiagnosed. To have a youth diagnosed, a
crisis in the school or home needs to occur, but, very seldom does a diagnosis result only

from a referral. Another problem is the lack of appropriate adolescent mental health

specialists and this is worse if attention to culturally relevant concerns is needed. If the

problems around getting a psychiatrist, psychologist or therapist are resolved, there
remains the issue of whether the youth will participate. One of the biggest problems in

getting youth to receive therapy is lack of motivation. For many youth, the only way they
will go to therapy is if the court mandates it. Social workers try in many ways to provide
this most needed service.

They search for appropriate mental programs in the

community, work with the schools and the families to obtain services through the school

system or DCF, and they provide short term counseling in the clients’ homes. The best

counseling sometimes has been done while shooting hoops, driving the youth to their
homes or having pizza.

Another successful intervention with a small number of
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participants has been psycho-educational groups run by the social workers that combine
emotional support with knowledge of the disease and recreational activities. Although

coming to the groups reminds them about their condition and as a result they are
sometimes reluctant to participate, these group meetings and the clinics are the only

times/places when they can freely talk, cry, be angry, sad or even happy.

Transmission of the disease is a main concern in the program and all the staff

work hard to encourage youth to disclose their status to their partner or partners. If the

youth feels comfortable to tell the partner, the staff works with both of them providing
education about the risks and risk reduction skills while testing the partner.

If the

adolescent is not up to the stage of disclosing, counseling is provided and if the name of a

partner or partners is given, a referral is done to the CARE program. This program will
contact the partner or partners and make them aware of the fact that they have been in
contact with a HIV infected person and need to be tested. Disclosure is very difficult for

adolescents; they fear rejection or physical aggression. If the young adolescent is going

through a period of turmoil with the family, usually they are looking for a way out and
getting involved with somebody who will provide a way out. In these situations, they are

usually not prepared to disclose their diagnosis to any of their sexual partners.

Adherence to medications in adolescents is a major factor in their lives and

changes according to their age, developmental stages, emotional status, relationships with
their friends and the family situation. If adherence among these 30 youth is based on

immunological classification, CD4 counts and viral loads, there would seem to be no
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problem in this study. This is due in large part to the support provided by the program to
ensure that the youth take the medications and the attention the program pays to the

broader aspects that impact these individuals when taking their medications. Doctors and
nurses make sure that each youth has the medical attention and tests needed such as

genotype and phenotype to best monitor their condition and provide them with the most
effective medications. The nurses are attentive to prescriptions and timely refills by

working with the youths’ families and pharmacies to ensure this happens. There is a
nurse dedicated to work with the youth having problems with adherence. Social workers

facilitate access to health care by working with the government or private health
insurance companies.

Since 90% of the adolescents in the study have government

insurance, the social workers work very closely with the families to stay current with all
the regulations needed to keep the insurance active. They also facilitate access to the
clinics by arranging transportation through the insurance covered medical services or

from community resources. In addition, the social workers also must pay close attention
to issues of poverty, mental heath, education, housing, legal issues and dual and triple

diagnoses that impact adherence. Overall, there is a conscious effort on the part of the
team of providers to educate the youth about the importance of taking their medications.

This educational process goes on in different ways; during clinical appointments,
individual counseling, home visits and support groups.

Also, adherence outcomes in this cohort of adolescents may have been helped by
the fact that five youth were in juvenile detention or mental health institutions where
medications are given. Also there were four youth that were not taking medications
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because their counts were not low enough to jeopardize their health. Three of them were

youth with heterosexual transmission and because their immune systems were formed
when infected it has allowed them to live without medication for some time. In addition,
two of the female youth were pregnant at the time and they were very concerned about

the importance of taking their medications to protect their babies from acquiring the HIV
infection. During pregnancy, they are monitored closely to make sure they are taking the

appropriate medication regimen to prevent the transmission of HIV to the baby.
Communication with the OB Gyn provider is very important to keep them adhering to

their HIV medication and to reinforce the education that the OB Gyn team provides to

them.

As a rule, those pregnant in the study have been very adherent to their

medications.

Although adherence to medications in general has been very good, in some
instances the lack of adherence was due to family disruption or other family issues, as in

the cases below:

A mother wanted to protect her adopted daughter from discrimination
in the rural community in which they lived; she did not allow the

hospital staff to disclose the diagnosis until the teen found out by
herself. The adolescent was so hurt by this deception that she became

extremely angry towards her adoptive mother and very depressed and
refused to take any medications. Although she stated that she hated
the medication, the underlining issues were her anger and depression.
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Working through this emotional response has been very difficult for
her and has severely jeopardized her health.

Another parent with concealed mental health and family issues has not

cooperated. She is an infected mother that does not take her own
medications and also refuses to give child medication. This is an

overwhelmed, depressed mother who is going through the process of a
divorce, has two children, the oldest one diagnosed with cerebral palsy
and the youngest with HIV and a chromosome syndrome.

The team’s commitment to maintain the health of these youth is intense. If an

appointment is missed, there is immediate telephone follow up to find out the reason for
not coming. If the phone call is not successful, a home visit will follow. In all, 77% of

the youth rated their communication with the hospital providers as good, although some
of them said that coming to the appointments reminded them of their HIV condition.

Chapter 5: Conclusion

On the important issue of medication adherence, causes for incomplete adherence,
as much of the literature review and the program results showed, could particularly be

due to the lack of knowledge about factors that presently affect adolescents. For some

adolescents, mental health problems can adversely affect adherence. Depression in
particular is a factor that is overlooked and under treated: other factors are lack of family
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or family support, and homelessness, which for adolescents means being on the street or

in shelters, or living with Mends or frequently changing living arrangements with various

relatives (none of these arrangement provides a stable environment that supports

adherence). Lack of psychological evaluations in the school system does not allow
sufficient attention to their behavioral as well as cognitive needs.

Poverty limits

comprehensive care. People with limited resources do not have access to appropriate
mental health services, eye care, dental care, etc. In other instances, poverty means

adolescents miss the basics, such as food and housing, or places them in situations where
violence is a way of life. Some youth in the program are in greater danger of dying

because of violence than from their HIV infection so adherence is the least of their
concerns.

We have learned that adherence interventions need to be tailored to the

adolescent’s individual needs, accounting for their biological, psychological and social
needs. These are continuously changing as the adolescent matures. Efforts to support
adherence are often hindered by lack of knowledge about what supports adolescent

adherence specifically and what will maintain adherence over time. Further studies are
needed to learn more about adolescents and the way they adhere to medications. These
studies should include social and environmental factors.

Pediatric and adolescent HIV is not disappearing and there is an urgent need to

bring it to the public’s attention. In addition to the cohort of children who acquired HIV
from their mothers, there are the adolescents who have been infected through sex or drug
addiction. HIV has been a predominately minority disease and most of the infected

adolescents live in deprived conditions. Many of these youths live in poverty, disrupted

58

families, and unfriendly environments and sometimes they have adopted unacceptable
behaviors to survive. Often these issues are compounded by cognitive deficiencies,
behavioral and mental problems. In addition to all these problems, HIV disease brings

other burdens, especially stigma, regardless of how they acquired it.

While the number of babies with HIV infection has dropped dramatically, there is
an increase in the number of adolescents acquiring HIV, mainly through unsafe sex. As a

result, the overall picture of adolescent HIV will continue to be with us in the US through
unsafe sex while mother to child transmission and adolescent acquisition of the disease

throughout the world will be a growing reality. Care providers for adolescents with HIV
must not only treat HIV but also these multiple and complex issues adolescents are

facing.

It is a difficult task to address the problems of HIV youth given the inadequacies
of existing systems. Looking at adolescent HIV as a whole, and taking into account the
care for HIV infected youth and prevention for the adolescents at risk, there is much
room for improvement. Many times in the planning for HIV programs and allocation of

funding, adolescents’ needs are not considered because it is assumed that they can be
covered in children or adult programs. This may have occurred because adolescence is a

period of constant transition from childhood to adolescent to adulthood. Frequently

people who plan and fund programs do not know how to assess youth needs or not want
to deal with an agency’s bureaucracy. An example of this is when the Department of

Public Health does a needs assessment and does not include youth because the process to
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obtain the required consent forms to interview a youth under 18 years old requires adult

consent as well.

If the care side is reviewed, the provision of medical care for HIV infected

adolescents has been part of government guidelines Nevertheless, there are areas that
need more attention, including mental health, dental care and substance abuse treatment.

Also, funding for ancillary services that make the care comprehensive (case management,
transportation, housing, client assistance) has been threatened in the last few years.

Existing medical programs dedicated to HIV positive adolescents have received more
attention because they are based in hospitals and the medical providers are more aware of

the adolescents’ transitions and needs. As seen in the literature review, medical providers
advocate for, and participate in, research in order to provide the care HIV positive
adolescents need.

On the other hand, HIV adolescent prevention has not enjoyed the same attention.
Prevention efforts have been paramount in mother to child transmission with very good
rates of success. The need to dedicate more attention to prevention in the adolescent

population has been demonstrated by government agencies.

Recent CDC reports have

stated that half of the people who are infected but unaware of their HIV infection are

young people (MMWR 2006). Also, The U.S. Department of Health Resources and
Service Administration (HRSA) recognizes the need to find people who are infected, get

them tested and linked to care. Based on these findings and recommendations adolescent

6O

prevention should be at the forefront in program development and funding, but

unfortunately it is not.

A combination of outreach and the use of new innovative technologies could
achieve the desired prevention for adolescents at risk of acquiring HIV. Rapid HIV

testing has made it easier to provide HIV testing in clinical and non-traditional settings.

Also, rapid tests produce results in 20 minutes, allowing the person to have the test
results in only one visit. Normally it has been proven that providing knowledge of the
disease has not been enough to change behaviors that put people at risk of getting HIV

but coupling it with results has a greater impact. Therefore, a number of behavioral
science based interventions called DEBIs (Diffusion of Effective Behavioral

Interventions) have been developed and recommended by CDC (MMWR 2006). In spite
of all the technological advances and the knowledge gained, adolescent prevention at

local and state levels has not reached the level required.

Since HIV infected persons are the source of infection for others, CDC has

promoted prevention interventions with HIV infected persons.

In 2003 CDC

implemented "The Advancing HIV Prevention Initiative" (MMWR 2006), which

formally adopted persons living with HIV as a core element in their prevention efforts.

However, again, at the local level, specific interventions for HIV infected youth were not
funded in the last prevention awards cycle.
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Because of low funding levels overall prevention for at risk and HIV infected
youth has been a low priority. The allocation of funding for very specific population
interventions (DEBIs) has been the priority for prevention awards for adults to the
detriment of funding for general outreach programs that were the ones who reached youth
out of networks such as men having sex with men (MSM), school drop outs and the

homeless.

This thesis has been a learning process. Applying the knowledge gained, the

author has disclosed recommendations for an ideal program for an adolescent HIV

program. An ideal program will encompass both care and prevention. In the area of care
the services need to be integrated and provided at one site. Therefore, HIV and primary
care that covers gynecology for the young female adolescents and similar care for the

male youth will be provided in one visit as needed. Adherence to medication will be an

important part of the care and based on individual assessment of the youth’s cognitive,

mental, behavioral and environmental factors. It will be done through different means:
the doctor, the nurse, groups or peer education and peer support. The medical and social

work staff will train the peers. Since the program is located at a children and adolescent

hospital or clinic, referrals for other medical needs will be taken care of by the specialties
in the hospital. Mental health will be an intrinsic part of the program and will have a

component with psychologist, therapist and case managers. Since the person that works

closely with the adolescent is the case manager, who is a graduate social worker, this
person will do the first assessment for mental health needs and provide the youth with a
referral for therapy or neuropsychological testing if needed. The role of the case manger
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as seen in the Montefiore Hospital program is crucial in making sure the youth receive

the services they need. Case managers will advocate for them with the schools, courts
and other needed services such as guiding youth through employment, post high school

education, employment and living skills to help youth transition to adulthood.

A prevention component has to be built into the adolescent program. This
prevention should have two parts, one for the HIV infected adolescents and the other for
the youth at risk to acquire HIV. Prevention for HIV infected youth is a public health

concern; therefore, it will be given special consideration. The whole team, medical and
social work staff should work on a protocol that will include the assessment of the

youths’ readiness to disclose their HIV status to their partner. Assessment for possible
violence is very important and proper support will be given during the process.

Counseling and testing will be offered to the partner or partners and risk reduction skills
will be taught. If the adolescents do not want to tell their partner/s, a referral to the

CARE program will be made.

Prevention for youth at risk will be done at the community level. This is a major

effort that no agency can do alone. A consortium of agencies that can bring significant
elements together and learn from each other will provide ideal outreach program.

Important issues such as identification of cultural issues in African-American, CaribbeanAmerican, Latino and Asian cultures is significant but overall, the adolescent culture is
what cuts across all these cultures. The knowledge of how to approach cohorts of youth
with specific behaviors common to all cultures, including heterosexual, MSM,
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transgender, and drug addicted, play a central role in any prevention outreach activity.
Information about other infections that put youth at risk of acquiring HIV such as

sexually transmitted diseases (STDs) is also crucial in any prevention intervention. It
will be most important to catch the attention of youth for the very serious issue of HIV

and STDs testing and counseling.

The UCHC/CCMC program has created a model called Hartford HIV
Identification and Linkage to Care (HYHIL) that has demonstrated ways to attract youth,

but has not been able to achieve the goal of unifying all youth oriented agencies to create
an adolescent prevention plan for the Greater Hartford area. The main barrier has been

the lack of funding for adolescent programs for the agencies and for the coordination of
the model.

Peer interventions have been proven effective in outreach. A project such as the
one at UCHC/CCMC called Teens Against Negligence

(TAN) trains adolescents

infected, affected and at risk to be peer educators. These youth provide prevention
education presentations to other peers and work in liaison with HYHIL to engage youth

in the community prevention activities where HIV/STD testing and counseling is done.

Work on adolescent HIV is a worthwhile effort to help positive youth in their

fight for a better life and to decrease the spread of the disease among youth at risk. All of
these HIV infected youths are in some way or another the victims of this disease; it is

imperative to continue helping them to obtain maximum achievement. There must be an
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increased awareness of the special needs of this population. They must not to be treated
as adults when their brains are still in development but as adolescents who are going

through a child to adult transition. Systems need to be sensitive and aware of the changes
of adolescence. Providers need to be caring enough to humbly accept and learn from the
sometimes negative responses of these youth and recognize their struggles living with
this disease.

As for prevention, until scientists find a cure, the communities and the
government as planners and funders need to recognize that a main way to diminish the
expansion of the epidemic is to pay attention to the youth at risk. The work in this field is
intensive and urgent. HIV prevention needs to be more powerful at the beginning of the

cycle of life. As much attention as was given to mother to child transmission, an even
stronger effort is needed to prevent young people from getting the infection and being a
source of new infections.

It would be ideal if communities could unite the scarce

financial resources and work together preventing the disease. It would be ideal if we

could curb the sources that promote inappropriate behavior in young people. All of us
lose if HIV continues its devastating course.
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Appendix

HIV MEDICATION ADHERENCE AND PSYCHOSOCIAL FACTORS

QUESTIONNAIRE

Age

Identification

Date of interview
SOCIO-DEMOGRAPHIC BACKGROUND
Gender"
Male

Female
Where do you live?
Hartford

Middletown

Manchester

New Britain

East Hartford

Other (specify)

Please mark the race/ethnicity you think you belong to:
African-American

Hispanic

White

Asian

Native American

Mix

Please indicate if any of the parents is dead"
Father

Yes

Mother

Yes

Both

Yes

7O

Living arrangements.

Biological mother

Father

Relatives

Adoptive Parents

Transient

Institution

Self

Parent’s caregiver education"
High school

Yes

No

College

Yes

No

Master

Yes

No

What type of housing do you live in?

Own housing

Rent housing

Sources of family income:
Employment

Government

Annual Income of household:

Less than

10,0000

10,000 20,000

20,000- 30,000
30,000 40,000
40,000- 50,000

More than- 50,000
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Both

Does your family own a car?
Yes

No

What kind of help do you receive?

Rent subsidy

Yes

No

Energy assistance

Yes

No

Food stamps

Yes

No

How important is religion in your life?

Very important

Someway important

No important

Does your family belong to any organization?
Community

Yes

No

School

Yes

No

Church

Yes

No

Volunteer

Yes

No

What programs or service you and your family use in the community

St. Juan Center

Salvation Army

CRT

Hispanic Health Council

Catholic Family Services

Food Pantries (specify)

Dpt. of Social Services

Police Department

Artists Collective

Recreational Programs

Ryan White Network
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DEVELOPMENTAL
What grade are you in school

not in school

If not in school what grade did you drop out

In the school what track are you in:

Honor

Academic

Adult

General

Special Ed.

Vocational

Have you had a psychological evaluation? Yes

No

What grades did you have last year? Most of them were:

A’s

B’s

D’s

C’s

F’s

Other

Have the mother/guardian been called to school because of problems?
Yes

No

How many times in the last year were you:
Suspended

Detained

Expelled

Have you been involved with DCF? Yes

No

If yes, why

Have you or anyone in your family used any type of drugs or alcohol in the last six
months?
Alcohol

Marihuana

Cocaine

Heroine

Other

Myself

1

2

3

4

5

Partner

1

2

3

4

5

Children

1

2

3

4

5
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Has your mom, caretaker ever been in jail?

Yes

No

Had any of your family ever been in jail?

Yes

No

Yes

No

Yes

No

If yes, why

Have you been in any juvenile detention?
If yes, why

Have you been in court?
If yes, why

None

How many close friends do you have?
Do you have friends of the opposite sex?

Yes

No

Do you have a boyfriend/girlfriend?

Yes

No

Are you sexually active?

Yes

No

If yes do you use protection (condoms)?

Yes

No

Does your partner know about your condition?

Yes

No

Do you have more than one partner?

Yes

No

If yes, how many

1

6-10

5

16-20

11-15

>20

What activities do you do with your friends?

Go to movies
Talk

Dance

Parks

Use marihuana

Drink

Sell drugs

other (specify)

Have you ever been abused?
Physical

Yes

No

Sexual

Yes

No

Emotional

Yes

No
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Malls

Clubs

Use other drug (specify)

Have you ever been depressed for more than two weeks?

Yes

No

Have you ever run away?

Yes

No

Have you ever thought about running away?

Yes

No

Have you ever been involved in a fight?

Yes

No

Have you ever witnessed violence at home or in the community? Yes

No

Have you ever had suicidal thoughts?

Yes

No

If yes, do you have a plan?

Yes

No

Have you had professional help (counseling)?

Yes

No

Do you participate in any group in the community?
Youth group

Church group

Community group

Sport groups

Art, music, theater group

Volunteer group

How many friends know about your diagnosis
What things make you happy?

Do you have a special person to share or talk when you are happy?

What things make you sad or depressed?
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When your are sad, depressed or feeling low what do you do. Do you talk to somebody?

HEALTH CARE
What kind of health insurance you have:

State

Private

How many times have you been in the emergency room in the last 6 months?
0

2

1

more than 3

3

How many times have you been hospitalized in the last 6 months?
0

1

2

more than 3

3

The following statement is about your health and your health providers.
Please explain to the respondent the values attached to the scale and ask him/her to
choose the value he/she thinks fit his/her family.

My communication with my doctor and nurse is:

11.,11

Good
1

3

2

4

Bad

5

I trust my health providers:
Distrust

1

2

3

4

5

I follow up with the referrals for other doctors:
Never

All the time
1

2

3

4

5
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Please say the name of your medication:

Knows: All

Some

None

Sometimes

Don’t take meds

I take the medications"
All the time

How many doses have you missed medications in the last 2 weeks?
0

1

3

2

4

>5

When do you miss most the medications?

AM

PM

What is the reason for missing medications?

Away from home

Forget

Slept through

Depressed

Concern with disclosure

Being in institution

Don’t feel sick

Don’t take medication

Do you understand the relationship between taking the meds & the lab results?
Yes

No

Youth source of infection:

Yes

No

Heterosexual Yes

No

IVDU

Yes

No

Transfusion

Yes

No

Perinatal
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OUTCOMES
Immunologic classification CD4"

N) No suppression (>500 CD4 )
A) Some suppression (500-200 CD4)
B) Severe suppression (< 200 CD4)

Viral load"

Undetectable

200- 1000

1000 5000

5000 -10000

10000 20000

20000 50000

50000

100000+

100000
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